Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Neuenhagen

9 clinical trials in Neuenhagen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Neuenhagen at a glance
9
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Neuenhagen

Open in trial search
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 DICHLOROBENZYL ALCOHOL
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Pharyngitis

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 DICHLOROBENZYL ALCOHOL
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Neuenhagen

What the registry says about research in the country

01 Seasonal Allergies Research

Clinical studies focusing on developing treatments for seasonal allergic rhinitis and rhinoconjunctivitis caused by grass and birch pollen exposure. Investigations include innovative immunotherapy approaches for both pediatric and adult populations.

  • Grass Pollen Allergies
  • Birch Pollen Sensitivity
  • Pediatric Allergy Management

Research aims to evaluate long-term effectiveness of immunotherapy treatments in reducing allergy symptoms.

02 Respiratory Health Studies

Comprehensive research on allergic rhinoconjunctivitis treatments, including studies of subcutaneous immunotherapy options. Special focus on moderate to severe cases, including patients with concurrent asthma symptoms.

  • House Dust Mite Allergies
  • Combined Allergy Treatments
  • Symptom Management

Trials evaluate both immediate symptom relief and long-term therapeutic benefits.

03 Immunotherapy Innovations

Advanced clinical investigations of mannan-conjugated allergoids and other novel immunotherapy approaches. Studies include double-blind placebo-controlled trials to ensure reliable efficacy assessment.

  • Novel Drug Delivery Methods
  • Allergoid Development
  • Treatment Safety Profiles

Research focuses on developing more effective and targeted allergy treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.